Bioactive Wound Care Market - Global Outlook and Forecast 2019-2024

PUBLISHED DATE : Nov 2019 | Pages : 287

Up to $1000 off Until Dec 2022

GLOBAL BIOACTIVE WOUND CARE MARKET SIZE TO CROSS USD 5.5 BILLION BY 2024, GROWING AT A CAGR OF OVER 6% DURING THE FORECAST PERIOD

Bioactive Wound Care Market Size, Share, Trends, Analysis Report by Products (Antimicrobial Dressings, Wound Care Biologics, Hydrocolloid Dressings, Alginate Dressings, and Collagen Dressings), Wound Type (Acute and Chronic), End-Users (Hospitals and Specialty Care Clinics, Long-Term Care Facilities, Home Healthcare, and Others), and Geography (North America, APAC, Europe, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Trends, Competitive Landscape, Share & Forecast, 2019–2024

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

287 Pages

icon-table

77 Tables

icon-chart

145 Charts

icon-region

5 Regions

icon-country

19 Countries

icon-company

36 Companies

icon-market

4 Market Segment

BIOACTIVE WOUND CARE MARKET SCOPE

Report Attribute Details
Market Size (REVENUE) USD 5.5 Billion (2024)
CAGR 6% (2019-2024)
Base Year 2018
Historic Year 2017
Forecast Year 2019 - 2024
Market Segments Products (Antimicrobial Dressings, Wound Care Biologics, Hydrocolloid Dressings, Alginate Dressings, and Collagen Dressings), Wound Type (Acute and Chronic), End-Users (Hospitals and Specialty Care Clinics, Long-Term Care Facilities, Home Healthcare, and Others)
Geographic Analysis North America, APAC, Europe, Latin America, and Middle East & Africa
Countries Covered US, Canada, Japan, China, India, South Korea, Australia, Germany, France, UK, Spain, Italy, Brazil, Mexico, Argentine, Turkey, Saudi Arabia ,South Africa, and Iran

INDUSTRY INSIGHTS

The introduction of smart bioactive wound dressing is likely to bring enormous business opportunities to the vendors in the market. 

The global bioactive wound care market size to cross USD 5.5 billion by 2024, growing at a CAGR of over 6% during the forecast period.  The increasing demand for innovative, effective, and proficient wound care products from surgeons as well as patients is expected to promote the market. With the availability of positive clinical evidences, demonstrating the superiority of newly launched advanced products, end-users are expected to adopt them as an alternative to other conventional products increasingly.

The growing incidence of chronic infection, including pressure ulcers, diabetic foot ulcers, venous ulcers as well as injuries related to burn, trauma, accidents, and surgery, is likely to increase the demand for innovative products. Favorable patient demographics is further driving manufacturers continue to launch new products. Another factor promoting development is their improved healing capacity and better clinical outcomes. In terms of geography, North America is leading, followed by Europe, APAC, Latin America, and MEA. The high growth of North America region can be attributed to the growing patient population suffering from acute and chronic infections due to the rise in lifestyle-related diseases such as diabetes.

The introduction of smart bioactive dressing is likely to bring exciting business opportunities for the vendors. Recent developments in the dressings with micro-fibers and biosensing for smart wound dressing enable quantitative, real-time representation of the wound environment, including pathogen concentrations, exudate levels, and tissue regeneration are likely to influence the market significantly.

BIOACTIVE WOUND CARE MARKET SEGMENTATION

This research report includes detailed segmentation by

  • Products
  • Wound type
  • End-users
  • Geography

INSIGHTS BY PRODUCTS

The growing wound management cost and the increasing population size with acute and chronic infections are increasing the demand for alginate dressings.

The antimicrobial wound dressings segment is growing due to the high prevalence of several chronic infections. The high demand for these dressings is leading to the introduction of a broad range of dressing offerings, which, in turn, are boosting the segment. Moreover, key vendors are focusing on several clinical trials to increase the efficacy of these dressings, thereby increasing market opportunities.

Wound biologics is the second largest segment of the bioactive wound care market. The segment is growing primarily due to the rising incidence of DFUs, venous ulcers, burn injuries, trauma, surgical site infections, and other accidental injuries globally. The increasing wound management cost and the increasing population size with various acute and chronic infections are increasing the demand for alginate dressings. Further, a wide range of commercially available alginate dressings is also driving the growth. Recently, several key players have offered silver-impregnated alginate dressings to treat the infections.

INSIGHTS BY WOUND TYPE

The phenomenal growth in surgical site infections is a key factor for the growth of the acute wound care segment

The bioactive wound care market is growing mainly on account of the rise in surgical procedures due to the growing incidence of chronic diseases. According to the WHO, approximately 234·2 million major surgical procedures are performed globally every year. The rise in surgical procedures, especially in the geriatric population, which also suffer from several acute and chronic diseases worldwide, is projected to influence the acute bioactive wound care segment. The phenomenal growth in the surgical site infections is another key factor for the growth of the segment. Furthermore, the number of burn cases is also increasing globally over the years. Therefore, the growing incidence of acute wounds and associated infections is fueling the growth of the segment.

INSIGHTS BY END-USERS

The application of several wound care products in home healthcare settings is expected to increase steadily during the forecast period

In 2018, the hospital & specialty care clinic segment was the leading end-user segment. The bioactive wound care market shares are growing mainly due to the increasing prevalence of acute infections, the growing number of surgical procedures, the increasing awareness of advanced products, and increasing number treatments being conducted in hospitals.

The long-term care facility segment is growing at a steady pace. The rise in incidences of chronic infections is growing due to the increasing patient population with lifestyle diseases such as diabetes. The growing elderly population is also contributing to the growth of the segment.

The home healthcare segment is witnessing the fastest CAGR in all other end-user segments. This segment is expected to increase steadily during the forecast period as the cost of hospital stay has significantly increased. Many vendors are also increasingly developing bioactive wound care products with features such as portability, ease of use, and low costs. The introduction of these features is likely to increase the adoption of in home healthcare settings.

INSIGHTS BY GEOGRAPHY

The increase in R&D for the development of innovative products will have a positive impact on the North American market

In 2018, North America was the largest region of the global bioactive wound care market. The growing population suffering from several acute and chronic infections is the primary factor for the high share. Europe is the second-largest market and the growth is on account of highly sophisticated healthcare infrastructure, the patient population with high awareness of bioactive wound care.

APAC is the fastest-growing market. The growing awareness of available treatment options and the increasing aging population are the major factors driving the growth. Favorable government initiatives and improved healthcare infrastructure are further driving the growth in the APAC region. Brazil, Mexico, and Argentina are the major revenue contributors in Latin America region. The growing incidence of several disease-related infections and the high prevalence of surgical infections are major drivers of the market.

Turkey, South Africa, Saudi Arabia, and Iran are the major revenue contributors to the MEA market. The market is growing due to the growing frequency of acute infections in the patient population with chronic diseases, high healthcare expenditure, and a large middle-class population with high spending power.

INSIGHTS BY VENDORS

The global bioactive wound care market is highly competitive and dynamic, characterized by the presence of many global, regional, and local vendors offering a diverse range of products for treating various acute and chronic infections. Approximately more than 300 vendors are offering a wide array of products worldwide. Multiple product launches, strategic acquisitions, and diversified product portfolio fueled their growth in recent years. New product launches and strategic acquisitions, collaborations, will be crucial for companies to maintain revenue growth in the coming years.

The bioactive wound care market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Segmentation by Products

  • Antimicrobial Dressings
  • Wound Care Dressings
  • Hydrocolloid Dressings
  • Alginate Dressings
  • Collagen Dressings

By Wound Type

  • Acute
  • Chronic

By End-users

  • Hospitals and Specialty Care Clinics
  • Long-term Care Facilities
  • Home Healthcare
  • Others (ASCs, solo practitioners, and other acute care settings)

By Geography

  • North America
    • US
    • Canada
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • Latin America
    • Brazil
    • Mexico
    • Argentine
  • MEA
    • Turkey
    • Saudi Arabia
    • South Africa
    • Iran

Frequently Asked Questions

What is the bioactive wound care market size and growth rate during the forecast period?

The global bioactive wound care market size to cross USD 5.5 billion by 2024, growing at a CAGR of over 6% during the forecast period

What are the factors influencing the growth of bioactive wound care market share?

The bioactive wound care market is growing mainly on account of the rise in surgical procedures due to the growing incidence of chronic diseases. The growing incidence of chronic infection, including pressure ulcers, diabetic foot ulcers, venous ulcers as well as injuries related to burn, trauma, accidents, and surgery, is likely to increase the demand for innovative products.

Which is the fastest growing end-user segment in the bioactive wound care market?

The home healthcare segment is witnessing the fastest CAGR in all other end-user segments. This segment is expected to increase steadily during the forecast period as the cost of hospital stay has significantly increased.

Who are the leading vendors in the market, and what are their market shares?

3M, Acelity, ConvaTec, Mölnlycke Health Care, PAUL HARTMANN, and Smith & Nephew Acelity are the leading vendors in the market.

Download Free Sample

The global bioactive wound care market is growing at a CAGR of over 6% during the forecast period 2018–2024.

 The following factors are likely to contribute to the growth of the market during the forecast period:

  • Increasing Incidences of Acute and Chronic Wounds
  • The emergence of Stem Cell Therapy
  • Growing Preference for Combination Dressings
  • High Demand for Medicated Wound Dressing Products

Base Year:                  2018

Forecast Year:           2019–2024

The study considers the present scenario of the bioactive wound care market and its market dynamics for the period 2018−2024. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply aspect of the market. The report profiles and examines leading companies and other prominent companies operating in the market.

Key Vendors

  • 3M
    • Business Overview
    • Major Product Offerings
    • Product Portfolio
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Acelity
  • ConvaTec
  • Mölnlycke Health Care
  • PAUL HARTMANN
  • Smith & Nephew Acelity

Prominent Vendors

  • Advanced Medical Solutions Group
    • Business Overview
    • Major Product Offerings
  • Advancis Medical
  • AediCell
  • AMERX Health Care
  • Aspen Surgical
  • Axio Biosolutions
  • B.Braun Melsungen
  • BD
  • BSN medical
  • BTI Biotechnology Institute
  • Cardinal Health
  • CGbio
  • Covalon Technologies
  • DermaRite Industries
  • DeRoyal Industries
  • Ethicon
  • Hollister
  • Integra LifeSciences
  • Kaken Pharmaceutical
  • Lohmann & Rauscher (L&R)
  • Medline Industries
  • MiMedx
  • MPM Medical
  • MTF Biologics
  • Organogenesis
  • SK Bioland
  • Sutherland Medical
  • TRIAGE MEDITECH
  • URGO Group
  • Vericel

 Market Segmentation by Products

  • Antimicrobial Dressings
  • Wound Care Dressings
  • Hydrocolloid Dressings
  • Alginate Dressings
  • Collagen Dressings

Market Segmentation by Wound Type

  • Acute
  • Chronic

Market Segmentation by End-users

  • Hospitals and Specialty Wound Care Clinics
  • Long-term Care Facilities
  • Home Healthcare
  • Others (ASCs, solo practitioners, and other acute care settings)

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • Latin America
    • Brazil
    • Mexico
    • Argentine
  • MEA
    • Turkey
    • Saudi Arabia
    • South Africa
    • Iran

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.2 Base Year

4.3 Scope of the study

4.4 Market Segments

4.4.1 Market Segmentation by Products

4.4.1 Market Segmentation by Wound Type

4.4.2 Market Segmentation by End-user Type

4.4.3 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at A Glance

7 Introduction

7.1 Bioactive Wound Care: Overview

7.1.1 Background

7.1.2 Bioactive Wound Care for Acute and Chronic Wounds

7.1.3 Bioactive Wound Care: Market Snapshot

8 Market Dynamics

8.1 Market Growth Enablers

8.1.1 Increasing Incidences of Acute and Chronic Wounds

8.1.2 Growing Preference for Tissue-Engineered Skin Substitutes and Growth Factors

8.1.3 High Demand for Medicated Dressing Products

8.2 Market Growth Restraints

8.2.1 High Cost of Bioactive Wound Care Products

8.2.2 Greater Availability of Substitutes for Bioactive Wound Care Products

8.2.3 Shortage of Adequate Resources for Bioactive Wound Care

8.3 Market Opportunities and Trends

8.3.1 Emergence of Stem Cell Therapy

8.3.2 Advent of Smart Bioactive Dressings

8.3.3 Growing Preference for Combination Dressings

9 Global Bioactive Wound Care Market

9.1 Market Overview

9.2 Market Size & Forecast

9.3 Five Forces Analysis

9.3.1 Threat of New Entrants

9.3.2 Bargaining Power of Suppliers

9.3.3 Bargaining Power of Buyers

9.3.4 Threat of Substitutes

9.3.5 Competitive Rivalry

10 Bioactive Wound Care Market by Product Type

10.1 Market Snapshot & Growth Engine

10.2 Market Overview

10.3 Antimicrobial Dressings

10.3.1 Market Overview

10.3.2 Market Size & Forecast

10.3.3 Antimicrobial Dressings: Segmentation by Geography

10.4 Wound Care Biologics

10.4.1 Market Overview

10.4.2 Market Size & Forecast

10.4.3 Wound Care Biologics: Segmentation by Geography

10.5 Hydrocolloid Dressings

10.5.1 Market Overview

10.5.2 Market Size & Forecast

10.5.3 Hydrocolloid Dressings: Segmentation by Geography

10.6 Alginate Dressings

10.6.1 Market Overview

10.6.2 Market Size & Forecast

10.6.3 Alginate Dressings: Segmentation by Geography

10.7 Collagen Dressings

10.7.1 Market Overview

10.7.2 Market Size & Forecast

10.7.3 Collagen Dressings: Segmentation by Geography

11 Bioactive Wound Care Market by Wound Type

11.1 Market Snapshot & Growth Engine

11.2 Market Overview

11.3 Acute Wounds

11.3.1 Market Overview

11.3.2 Market Size & Forecast

11.4 Chronic Wounds

11.4.1 Market Overview

11.4.2 Market Size & Forecast

12 Bioactive Wound Care Market by End Users

12.1 Market Snapshot & Growth Engine

12.2 Market Overview

12.3 Hospitals & Specialty Wound Care Clinics

12.3.1 Market Overview

12.3.2 Market Size & Forecast

12.4 Long-term Care Facilities

12.4.1 Market Overview

12.4.2 Market Size & Forecast

12.5 Home Healthcare

12.5.1 Market Overview

12.5.2 Market Size & Forecast

12.6 Others

12.6.1 Market Overview

12.6.2 Market Size & Forecast

13 Bioactive Wound Care Market by Geography

13.1 Market Snapshot & Growth Engine

13.2 Overview

14 North America

14.1 Market Overview

14.2 Market Size & Forecast

14.3 Segmentation by Product Type

14.4 Key Countries

14.4.1 US: Market Size & Forecast

14.4.2 Canada: Market Size & Forecast

15 Europe

15.1 Market Overview

15.2 Market Size & Forecast

15.3 Segmentation by Product Type

15.4 Key Countries

15.4.1 Germany: Market Size & Forecast

15.4.2 France: Market Size & Forecast

15.4.3 UK: Market Size & Forecast

15.4.4 Spain: Market Size & Forecast

15.4.5 Italy: Market Size & Forecast

16 APAC

16.1 Market Overview

16.2 Market Size & Forecast

16.3 Segmentation by Product Type

16.4 Key Countries

16.4.1 China: Market Size & Forecast

16.4.2 Japan: Market Size & Forecast

16.4.3 India: Market Size & Forecast

16.4.4 South Korea: Market Size & Forecast

16.4.5 Australia: Market Size & Forecast

17 Latin America

17.1 Market Overview

17.2 Market Size & Forecast

17.3 Segmentation by Product Type

17.4 Key Countries

17.4.1 Brazil: Market Size & Forecast

17.4.2 Mexico: Market Size & Forecast

17.4.3 Argentina: Market Size & Forecast

18 Middle-East & Africa

18.1 Market Overview

18.2 Market Size & Forecast

18.3 Segmentation by Product Type

18.4 Key Countries

18.4.1 Turkey: Market Size & Forecast

18.4.2 South Africa: Market Size & Forecast

18.4.3 Saudi Arabia: Market Size & Forecast

18.4.4 Iran: Market Size & Forecast

19 Competitive Landscape

19.1 Competition Overview

19.2 Market Share Analysis

20 Key Company Profiles

20.1 Smith & Nephew

20.1.1 Business Overview

20.1.2 Major Product Offerings

20.1.3 Smith & Nephew in Global Bioactive Wound Care Market

20.1.4 Key Strengths

20.1.5 Key Strategies

20.1.6 Key Opportunities

20.2 Mölnlycke Health Care

20.2.1 Business Overview

20.2.2 Major Product Offerings

20.2.3 Mölnlycke Health Care in Global Bioactive Wound Care Market

20.2.4 Key Strengths

20.2.5 Key Strategies

20.2.6 Key Opportunities

20.3 Acelity

20.3.1 Business Overview

20.3.2 Major Product Offerings

20.3.3 Acelity in Global Bioactive Wound Care Market

20.3.4 Key Strengths

20.3.5 Key Strategies

20.3.6 Key Opportunities

20.4 ConvaTec

20.4.1 Business Overview

20.4.2 Major Product Offerings

20.4.3 ConvaTec in Global Bioactive Wound Care Market

20.4.4 Key Strengths

20.4.5 Key Strategies

20.4.6 Key Opportunities

20.5 3M

20.5.1 Business Overview

20.5.2 Major Product Offerings

20.5.3 3M in Global Bioactive Wound Care Market

20.5.4 Key Strengths

20.5.5 Key Strategies

20.5.6 Key Opportunities

20.6 PAUL HARTMANN

20.6.1 Business Overview

20.6.2 Major Product Offerings

20.6.3 PAUL HARTMANN in Global Bioactive Wound Care Market

20.6.4 Key Strengths

20.6.5 Key Strategies

20.6.6 Key Opportunities

21 Other Prominent Vendors

21.1 Advanced Medical Solutions Group

21.1.1 Business Overview

21.1.2 Major Product Offerings

21.2 Advancis Medical

21.2.1 Business Overview

21.2.2 Major Product Offerings

21.3 Aedicell

21.3.1 Business Overview

21.3.2 Major Product Offerings

21.4 AMERX Health Care

21.4.1 Business Overview

21.4.2 Major Product Offerings

21.5 Aspen Surgical

21.5.1 Business Overview

21.5.2 Major Product Offerings

21.6 Axio Biosolutions

21.6.1 Business Overview

21.6.2 Major Product Offerings

21.7 B. Braun Melsungen

21.7.1 Business Overview

21.7.2 Major Product Offerings

21.8 BD

21.8.1 Business Overview

21.8.2 Major Product Offerings

21.9 BSN medical

21.9.1 Business Overview

21.9.2 Major Product Offerings

21.10 BTI Biotechnology Institute

21.10.1 Business Overview

21.10.2 Major Product Offerings

21.11 Cardinal Health

21.11.1 Business Overview

21.11.2 Major Product Offerings

21.12 CGbio

21.12.1 Business Overview

21.12.2 Major Product Offerings

21.13 Covalon Technologies

21.13.1 Business Overview

21.13.2 Major Product Offerings

21.14 DermaRite Industries

21.14.1 Business Overview

21.14.2 Major Product Offerings

21.15 DeRoyal Industries

21.15.1 Business Overview

21.15.2 Major Product Offerings

21.16 Ethicon

21.16.1 Business Overview

21.16.2 Major Product Offerings

21.17 Hollister

21.17.1 Business Overview

21.17.2 Major Product Offerings

21.18 Intergra LifeSciences

21.18.1 Business Overview

21.18.2 Major Product Offerings

21.19 Kaken Pharmaceutical

21.19.1 Business Overview

21.19.2 Major Product Offerings

21.2 Lohmann & Rauscher (L&R)

21.20.1 Business Overview

21.20.2 Major Product Offerings

21.21 Medline Industries

21.21.1 Business Overview

21.21.2 Major Product Offerings

21.22 MiMedx

21.22.1 Business Overview

21.22.2 Major Product Offerings

21.23 MPM Medical

21.23.1 Business Overview

21.23.2 Major Product Offerings

21.24 MTF Biologics

21.24.1 Business Overview

21.24.2 Major Product Offerings

21.25 Organogenesis

21.25.1 Business Overview

21.25.2 Major Product Offerings

21.26 SK Bioland

21.26.1 Business Overview

21.26.2 Major Product Offerings

21.27 Sutherland Medical

21.27.1 Business Overview

21.27.2 Major Product Offerings

21.28 TRIAGE MEDITECH

21.28.1 Business Overview

21.28.2 Major Product Offerings

21.29 URGO Group

21.29.1 Business Overview

21.29.2 Major Product Offerings

21.3 Vericel

21.30.1 Business Overview

21.30.2 Major Product Offerings

22 Report Summary

22.1 Key Takeaways

22.2 Strategic Recommendations

22.3 Quantitative Summary

22.3.1 By Product Type

22.3.2 By Wound Type

22.3.3 By End-users

22.3.4 By Geography

22.3.5 Antimicrobial Dressings Market by Geography

22.3.6 Wound Care Biologics Market by Geography

22.3.7 Hydrocolloid Dressings Market by Geography

22.3.8 Alginate Dressings Market by Geography

22.3.9 Collagen Dressings Market by Geography

22.3.10 North America: Segmentation by Product Type

22.3.11 Europe: Segmentation by Product Type

22.3.12 APAC: Segmentation by Product Type

22.3.13 Latin America: Segmentation by Product Type

22.3.14 MEA: Segmentation by Product Type

23 Appendix

23.1 Abbreviations

List of Exhibits 

Exhibit 1               Segmentation of Global Bioactive Wound Care Market

Exhibit 2               Market Size Calculation Approach 2018

Exhibit 3               Major Market Dynamics in Bioactive Wound Care Market

Exhibit 4               Impact of Increasing Incidences of Acute and Chronic Wounds

Exhibit 5               Prevalence of MCCs in Selected Regions (%)

Exhibit 6               Impact of Growing Preference for Tissue-Engineered Skin Substitutes and Growth Factors

Exhibit 7               Key Advantages of Growth Factor Therapy

Exhibit 8               Impact of High Demand for Medicated Dressing Products

Exhibit 9               Key Benefits of Antimicrobial Dressings

Exhibit 10             Impact of High Cost of Bioactive Wound Care Products

Exhibit 11             Impact of Greater Availability of Substitutes

Exhibit 12             Impact of Shortage of Adequate Resources

Exhibit 13             Impact of Emergence of Stem Cell Therapy

Exhibit 14             Impact of Advent of Smart Bioactive Wound Dressings

Exhibit 15             Impact of Growing Preference for Combination Dressings

Exhibit 16             Global Bioactive Wound Care Market: Overview

Exhibit 17             Global Bioactive Wound Care Market 2018−2024 ($ million)

Exhibit 18             Market by Geography 2018 & 2024 (%)

Exhibit 19             Market by Product Type 2018 & 2024 (%)

Exhibit 20             Market by Wound Type 2018 & 2024 (%)

Exhibit 21             Market by End-users 2018 & 2024 (%)

Exhibit 22             Five Force Analysis 2018

Exhibit 23             Incremental Growth by Product Type 2018-2024

Exhibit 24             Global Bioactive Wound Care Market by Product Type

Exhibit 25             Market by Product: Incremental Growth

Exhibit 26             Market by Product: Absolute Growth

Exhibit 27             Market by Product 2018 & 2024 (%)

Exhibit 28             Market by Product Type 2018−2024 ($ million)

Exhibit 29             Market by Product 2018−2024 (%)

Exhibit 30             Global Antimicrobial Dressings Market 2018−2024 ($ million)

Exhibit 31             Market: Segmentation by Geography 2018 & 2024 (%)

Exhibit 32             Market: Segmentation by Geography 2018−2024 ($ million)

Exhibit 33             Market: Segmentation by Geography 2018−2024 (%)

Exhibit 34             Key Advantages of Growth Factor Therapy

Exhibit 35             Global Wound Care Biologics Market 2018−2024 ($ million)

Exhibit 36             Market: Segmentation by Geography 2018 & 2024 (% share)

Exhibit 37             Market Segmentation by Geography 2018−2024 ($ million)

Exhibit 38             Market Segmentation by Geography 2018−2024 (% share)

Exhibit 39             Global Hydrocolloid Dressings Market 2018−2024 ($ million)

Exhibit 40             Market Segmentation by Geography 2018 & 2024 (%)

Exhibit 41             Market: Segmentation by Geography 2018−2024 ($ million)

Exhibit 42             Market Segmentation by Geography 2018−2024 (%)

Exhibit 43             Global Alginate Dressings Market 2018−2024 ($ million)

Exhibit 44             Market: Segmentation by Geography 2018 & 2024 (%)

Exhibit 45             Market: Segmentation by Geography 2018−2024 ($ million)

Exhibit 46             Market: Segmentation by Geography 2018−2024 (%)

Exhibit 47             Global Collagen Dressings Market Size 2018−2024 ($ million)

Exhibit 48             Market: Segmentation by Geography 2018 & 2024 (% share)

Exhibit 49             Market: Segmentation by Geography 2018 & 2024 ($ million)

Exhibit 50             Market: Segmentation by Geography 2018 & 2024 (%)

Exhibit 51             Incremental Growth by Wound Type

Exhibit 52             Global Bioactive Wound Care Market by Wound Type

Exhibit 53             Market by Wound Type: Incremental Growth

Exhibit 54             Market by Wound Type: Absolute Growth

Exhibit 55             Market by Wound Type 2018 & 2024 (%)

Exhibit 56             Market by Wound Type 2018−2024 ($ million)

Exhibit 57             Market by Wound Type 2018−2024 (%)

Exhibit 58             Global Acute Wounds 2018 (% share revenue)

Exhibit 59             Global Bioactive Acute Wound Care Market 2018−2024 ($ million)

Exhibit 60             Revenue Share of Various Chronic Wounds 2018(%)

Exhibit 61             Global Bioactive Chronic Wounds Market 2018−2024 ($ million)

Exhibit 62             Incremental Growth by End-users 2018-2024

Exhibit 63             Global Bioactive Wound Care Market by End Users

Exhibit 64             Market by End-users: Incremental Growth

Exhibit 65             Market by End-users: Absolute Growth

Exhibit 66             Market by End-users 2018 & 2024 (%)

Exhibit 67             Market by End-users 2018−2024 ($ million)

Exhibit 68             Market by End-users 2018−2024 (%)

Exhibit 69             Market by Hospitals and Specialty Wound Care Clinics 2018−2024 ($ million)

Exhibit 70             Market by Long-term Care Facilities ($ million)

Exhibit 71             Market by Home Healthcare 2018−2024 ($ million)

Exhibit 72             Market by Other End-users 2018−2024 ($ million)

Exhibit 73             Incremental Growth by Geography 2018-2024

Exhibit 74             Global Bioactive Wound Care Market by Geography

Exhibit 75             Market by Geography: Absolute Growth

Exhibit 76             Market by Geography: Incremental Growth

Exhibit 77             Market by Geography 2018 & 2024 (%)

Exhibit 78             Market by Geography 2018−2024 ($ million)

Exhibit 79             Market by Geography 2018−2024 (%)

Exhibit 80             Market by Geography: Key Countries ($ million)

Exhibit 81             Bioactive Wound Care Market in North America: Key Countries

Exhibit 82             Market in North America 2018−2024 ($ million)

Exhibit 83             Market in North America by Product Type 2018 & 2024 (% share)

Exhibit 84             Market in North America by Product 2018−2024 ($ million)

Exhibit 85             Market in North America by Product 2018−2024 (%)

Exhibit 86             Incremental Growth in North America 2018-2024

Exhibit 87             Market in US 2018−2024 ($ million)

Exhibit 88             Market in Canada 2018−2024 ($ million)

Exhibit 89             Bioactive Wound Care Market in Europe

Exhibit 90             Diabetes Prevalence Rate among Women in Europe by Age Group 2017 (% share)

Exhibit 91             Diabetes Prevalence Rate among Men in Europe by Age Group 2017 (% share)

Exhibit 92             Bioactive Wound Care Market in Europe 2018–2024 ($ million)

Exhibit 93             Market in Europe by Product Type 2018 & 2024 (% share)

Exhibit 94             Market in Europe by Product Type 2018− 2024 ($ million)

Exhibit 95             Market in Europe by Product Type 2018−2024 (% share)

Exhibit 96             Incremental Growth in Europe 2018−2024

Exhibit 97             Market in Germany 2018–2024 ($ million)

Exhibit 98             Prevalence of Leg Ulcers in Various Age Group in France (% share)

Exhibit 99             Market in France 2018–2024 ($ million)

Exhibit 100          Market in UK 2018–2024 ($ million)

Exhibit 101          Prevalence of Diabetes in Spain 2017 (%)

Exhibit 102          Market in Spain 2018–2024 ($ million)

Exhibit 103          Market in Italy 2018–2024 ($ million)

Exhibit 104          Bioactive Wound Care Market in APAC – Key Countries

Exhibit 105          Market in APAC 2018−2024 ($ million)

Exhibit 106          Market in APAC by Product Type 2018 & 2024 (%)

Exhibit 107          Market in APAC by Product Type 2018−2024 ($ million)

Exhibit 108          Market in APAC by Product Type 2018−2024 (% share)

Exhibit 109          Incremental Growth in APAC

Exhibit 110          Prevalence of Diabetes in Adults in China (% share) 2017

Exhibit 111          Market in China 2018–2024 ($ million)

Exhibit 112          Incidence Rates of SSI in Japan 2016 (% share)

Exhibit 113          Market in Japan 2018–2024 ($ million)

Exhibit 114          Market in India 2018–2024 ($ million)

Exhibit 115          Market in South Korea 2018–2024 ($ million)

Exhibit 116          Market in Australia 2018–2024 ($ million)

Exhibit 117          Bioactive Wound Care Market in Latin America: Key Countries

Exhibit 118          Market in Latin America 2018−2024 ($ million)

Exhibit 119          Market in Latin America by Product 2018 & 2024 (% share)

Exhibit 120          Market in Latin America by Product Type 2018− 2024 ($ million)

Exhibit 121          Market in Latin America by Product Type 2018−2024 (% share)

Exhibit 122          Incremental Growth in Latin America

Exhibit 123          Market in Brazil 2018−2024 ($ million)

Exhibit 124          Market in Mexico 2018−2024 ($ million)

Exhibit 125          Market in Argentina 2018−2024 ($ million)

Exhibit 126          Bioactive Wound Care Market in MEA – Key Countries

Exhibit 127          Diabetes Prevalence Rate in Women in MEA by Age Group 2017 (% share)

Exhibit 128          Diabetes Prevalence Rate in Men in MEA by Age Group 2017 (% share)

Exhibit 129          Bioactive Wound Care Market in MEA 2018−2024 ($ million)

Exhibit 130          Market in MEA by Product Type 2018 & 2024 (%)

Exhibit 131          Market in MEA by Product Type 2018−2024 ($ million)

Exhibit 132          MEA Bioactive Wound Care Market Segmentation by Product Type 2018−2024 (%)

Exhibit 133          Incremental Growth in MEA

Exhibit 134          Market in Turkey 2018−2024 ($ million)

Exhibit 135          Market in South Africa 2018−2024 ($ million)

Exhibit 136          Market in Saudi Arabia 2018−2024 ($ million)

Exhibit 137          Market in Iran 2018−2024 ($ million)

Exhibit 138          Market: Vendors Market Share by Tier 2018 (%)

Exhibit 139          Smith & Nephew: R&D Expenditure 2016−2018 ($ million)

Exhibit 140          Smith & Nephew: Revenue by Product Category 2017−2018 ($ million)

Exhibit 141          Smith & Nephew: Revenue Based on Geographic Segments (%)

Exhibit 142          ConvaTec: R&D Expenditure 2016-2018 ($ million)

Exhibit 143          ConvaTec: Revenue by Franchise 2017-2018 ($ million)

Exhibit 144          ConvaTec: Revenue by Geography (%)

Exhibit 145          3M: Revenue by Geography (% share)

               

List of Tables    

Table 1                  Key Caveats

Table 2                  Currency Conversion 2013−2018

Table 3                  Major Players Offering Wound Biologics

Table 4                  Companies Offering Antimicrobial Dressings

Table 5                  Key Alternative Bioactive Wound Care Products

Table 6                  Key Advantages of Few Collagen-Based Combination Dressings

Table 7                  Significant Players Offering Combination Dressings

Table 8                  Key Commercially Available Antimicrobial Dressings

Table 9                  Key Commercially Available Wound Biologics Products

Table 10               Significant Commercially Available Hydrocolloid Dressings

Table 11               Key Commercially Available Alginate Dressings

Table 12               Key Commercially Available Collagen Dressings

Table 13               Prevalence of Several Acute and Chronic Wounds in Germany (% share)

Table 14               Smith & Nephew: Key Product Offerings

Table 15               Mölnlycke Health Care: Key Product Offerings

Table 16               Acelity: Key Product Offerings

Table 17               ConvaTec: Key Product Offerings

Table 18               3M: Key Product Offerings

Table 19               PAUL HARTMANN: Key Product Offerings

Table 20               Advanced Medical Solutions Group: Key Product Offerings

Table 21               Advancis Medical: Key Product Offerings

Table 22               Aedicell: Key Product Offerings

Table 23               AMERX Health Care: Key Product Offerings

Table 24               Aspen Surgical: Key Product Offerings

Table 25               Axio Biosolutions: Key Product Offerings

Table 26               B. Braun Melsungen: Key Product Offerings

Table 27               BD: Key Product Offerings

Table 28               BSN medical: Key Product Offerings

Table 29               BTI Biotechnology Institute: Key Product Offerings

Table 30               Cardinal Health: Key Product Offerings

Table 31               CGbio: Key Product Offerings

Table 32               Covalon Technologies: Key Product Offerings

Table 33               DermaRite Industries: Key Product Offerings

Table 34               DeRoyal Industries: Key Product Offerings

Table 35               Ethicon: Key Product Offerings

Table 36               Hollister: Key Product Offerings

Table 37               Integra LifeSciences: Key Product Offerings

Table 38               Kaken Pharmaceutical: Key Product Offerings

Table 39               LOHMANN & RAUSCHER (L&R): Key Product Offerings

Table 40               Medline Industries: Key Product Offerings

Table 41               MiMedx: Key Product Offerings

Table 42               MPM Medical: Key Product Offerings

Table 43               MTF Biologics: Key Product Offerings

Table 44               Organogenesis: Key Product Offerings

Table 45               SK Bioland: Key Product Offerings

Table 46               Sutherland Medical: Key Product Offerings

Table 47               TRIAGE MEDITECH: Key Product Offerings

Table 48               URGO Group: Key Product Offerings

Table 49               Vericel: Key Product Offerings

Table 50               Global Bioactive Wound Care Market by Products ($ million)

Table 51               Market by Products (%)

Table 52               Global Bioactive Wound Care Market by Wound Type ($ million)

Table 53               Market by Wound Type (%)

Table 54               Global Bioactive Wound Care Market by End-users ($ million)

Table 55               Market by End-users (%)

Table 56               Global Bioactive Wound Care Market by Geography ($ million)

Table 57               Market by Geography (%)

Table 58               Global Antimicrobial Dressings Market by Geography ($ million)

Table 59               Market by Geography ($ million) (%)

Table 60               Global Wound Care Biologics Market by Geography ($ million)

Table 61               Market by Geography ($ million) (%)

Table 62               Global Hydrocolloid Dressings Market by Geography ($ million)

Table 63               Market by Geography ($ million) (%)

Table 64               Global Alginate Dressings Market by Geography ($ million)

Table 65               Market by Geography ($ million) (%)

Table 66               Global Collagen Dressings Market by Geography ($ million)

Table 67               Market by Geography ($ million) (%)

Table 68               Bioactive Wound Care Market in North America by Product Type ($ million)

Table 69               Market in North America by Product Type (%)

Table 70               Bioactive Wound Care Market in Europe by Product Type ($ million)

Table 71               Market in Europe by Product Type (%)

Table 72               Bioactive Wound Care Market in APAC by Product Type ($ million)

Table 73               Market in APAC by Product Type (%)

Table 74               Bioactive Wound Care Market in Latin America by Product Type ($ million)

Table 75               Market in Latin America by Product Type (%)

Table 76               Bioactive Wound Care Market in MEA by Product Type ($ million)

Table 77               Market in MEA by Product Type (%)

Select a license type that suits your business needs

single-user Single User Licence
$2800.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$3200.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$4000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1200.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

20%

Off

OFF

DAYS

HOURS

MINUTES

SECONDS

Licence Types What are these?

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date